Poinciana Advisors Group LLC trimmed its holdings in shares of Teradyne, Inc. (NASDAQ:TER – Free Report) by 54.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,382 shares of the company’s stock after selling 1,633 shares during the quarter. Teradyne comprises about 0.5% of Poinciana Advisors Group LLC’s holdings, making the stock its 16th largest position. Poinciana Advisors Group LLC’s holdings in Teradyne were worth $669,000 at the end of the most recent quarter.
A number of other institutional investors have also added to or reduced their stakes in TER. State Street Corp raised its holdings in shares of Teradyne by 0.9% in the 4th quarter. State Street Corp now owns 7,078,635 shares of the company’s stock valued at $1,370,141,000 after acquiring an additional 60,986 shares in the last quarter. Ameriprise Financial Inc. grew its holdings in shares of Teradyne by 3.0% during the second quarter. Ameriprise Financial Inc. now owns 4,920,100 shares of the company’s stock worth $442,413,000 after purchasing an additional 143,058 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of Teradyne by 18.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 4,203,546 shares of the company’s stock worth $813,640,000 after purchasing an additional 659,273 shares in the last quarter. Invesco Ltd. increased its position in shares of Teradyne by 3.5% in the third quarter. Invesco Ltd. now owns 2,959,330 shares of the company’s stock worth $407,322,000 after purchasing an additional 99,864 shares during the last quarter. Finally, Morgan Stanley increased its position in shares of Teradyne by 1.9% in the fourth quarter. Morgan Stanley now owns 2,442,014 shares of the company’s stock worth $472,677,000 after purchasing an additional 45,089 shares during the last quarter. 99.77% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
TER has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. raised shares of Teradyne from a “neutral” rating to an “overweight” rating and set a $400.00 target price on the stock in a research note on Thursday, April 30th. Stifel Nicolaus boosted their price target on shares of Teradyne from $325.00 to $390.00 and gave the stock a “buy” rating in a research note on Tuesday, April 28th. Weiss Ratings raised shares of Teradyne from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, August 6th. The Goldman Sachs Group restated a “buy” rating and set a $465.00 price objective on shares of Teradyne in a research report on Tuesday, July 28th. Finally, Morgan Stanley lifted their price objective on shares of Teradyne from $387.00 to $397.00 and gave the stock an “equal weight” rating in a report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $396.80.
Insider Buying and Selling
In other news, insider Shannon John Poulin sold 1,008 shares of the business’s stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $345.37, for a total value of $348,132.96. Following the completion of the sale, the insider directly owned 15,066 shares in the company, valued at approximately $5,203,344.42. The trade was a 6.27% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Gregory Stephen Smith sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $423.03, for a total transaction of $1,692,120.00. Following the completion of the sale, the chief executive officer owned 120,470 shares of the company’s stock, valued at approximately $50,962,424.10. The trade was a 3.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 5,664 shares of company stock worth $2,273,133 over the last quarter. Company insiders own 0.19% of the company’s stock.
Teradyne Trading Up 1.9%
TER opened at $410.52 on Friday. The stock has a market capitalization of $64.18 billion, a P/E ratio of 56.31, a PEG ratio of 0.81 and a beta of 1.78. The stock has a 50-day moving average price of $383.05 and a 200-day moving average price of $347.89. Teradyne, Inc. has a 12-month low of $106.30 and a 12-month high of $487.91.
Teradyne (NASDAQ:TER – Get Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The company reported $2.47 earnings per share for the quarter, beating analysts’ consensus estimates of $2.09 by $0.38. The company had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.22 billion. Teradyne had a return on equity of 39.93% and a net margin of 25.77%.Teradyne’s revenue for the quarter was up 103.9% compared to the same quarter last year. During the same period last year, the firm posted $0.57 EPS. On average, equities research analysts predict that Teradyne, Inc. will post 9.1 EPS for the current year.
About Teradyne
Teradyne, Inc is a global supplier of automatic test equipment and related services principally used to test semiconductors, wireless products and complex electronic systems. Founded in 1960, the company is headquartered in North Reading, Massachusetts, and has a long history of developing capital equipment and software that help semiconductor manufacturers, electronics OEMs and contract manufacturers validate product performance and reliability during design and production.
The company’s product portfolio centers on automatic test equipment (ATE) and system-level test solutions that address chip- and board-level validation, burn-in and reliability screening.
Featured Stories
- Five stocks we like better than Teradyne
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Want to see what other hedge funds are holding TER? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teradyne, Inc. (NASDAQ:TER – Free Report).
Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.
